IGM Biosciences Inc (NAS:IGMS)
$ 17.25 -0.57 (-3.2%) Market Cap: 1.02 Bil Enterprise Value: 840.64 Mil PE Ratio: 0 PB Ratio: 8.34 GF Score: 30/100

IGM Biosciences Inc at Jefferies Virtual London Healthcare Conference Transcript

Nov 17, 2020 / 07:20PM GMT
Release Date Price: $53.77 (-0.43%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Welcome, everyone, to the Jefferies London Virtual Health Care Conference. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. And I'd like to welcome our next company, IGM Biosciences and their CEO, Fred Schwartzer. So welcome, Fred, for participating in this fireside.

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Thanks very much. Really appreciate the opportunity.

Questions & Answers

Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

So maybe to start off for those that aren't not familiar with IGM. You have a unique monoclonal antibody platform in researching and developing IGM, format monoclonal antibodies. Maybe just talk about this platform relative to the IgG peers.

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Sure. That's my pleasure. Well, let me step

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot